SCHEMBL24448756

SCHEMBL24448756

COCCc1nn(Cc2ccc(OC)cc2)cc1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.45
▸ NPC1 O15118 2/20 0.45
▸ RAB9A P51151 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ HDAC1 Q13547 2/20 0.44
▸ HDAC7 Q8WUI4 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ AADAT Q8N5Z0 1/20 0.42
▸ KLKB1 P03952 4/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ SNCA P37840 1/20 0.40
▸ HSP90AA1 P07900 1/20 0.40
▸ HSP90AB1 P08238 1/20 0.40
▸ CALM1 P0DP23 1/20 0.40
▸ CMA1 P23946 1/20 0.40
▸ DCTPP1 Q9H773 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24448755 0.83 AADAT (0.40) MEN1NPC1RAB9AKMT2AHDAC1
SCHEMBL24449893 0.83 HSP90AA1 (0.45) MEN1NPC1RAB9AKMT2AHDAC1
SCHEMBL19170474 0.81 MEN1 (0.52) MEN1NPC1RAB9AKMT2AKDM4E
SCHEMBL24449775 0.78 SMN1; SMN2 (0.37) MEN1NPC1RAB9AKMT2AKLKB1
SCHEMBL21245036 0.77 MEN1 (0.49) MEN1NPC1RAB9AKMT2AKDM4E
SCHEMBL27090763 0.76 MEN1 (0.46) MEN1NPC1RAB9AKMT2AHDAC1
SCHEMBL370625 0.74 MEN1 (0.44) MEN1NPC1RAB9AKMT2AHDAC1
SCHEMBL369027 0.73 KLKB1 (0.51) KMT2AKLKB1CMA1
SCHEMBL370508 0.73 KMT2A (0.53) MEN1NPC1RAB9AKMT2AKLKB1
SCHEMBL25947865 0.73 RAB9A (0.41) MEN1NPC1RAB9AKMT2AHDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11685732-B2 MYST family histone acetyltransferase inhibitors Epizyme, Inc. (US) 2023-06-27 — — US disclosed
US-11685732-B2 MYST family histone acetyltransferase inhibitors Epizyme, Inc. (US) 2023-06-27 — — US disclosed
US-20220162197-A1 MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS Epizyme, Inc. 2022-05-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220162197-A1 MYST FAMILY HISTONE ACETYLTRANSFERASE INHIBITORS EP300, KAT2A, KAT6A MEN1 1860/4885NPC1 329/4885RAB9A 2422/4885
US-11685732-B2 MYST family histone acetyltransferase inhibitors EP300, KAT2A, KAT6A MEN1 1860/4885NPC1 329/4885RAB9A 2422/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback